<?xml version="1.0" encoding="UTF-8"?>
<ref id="B166-biomolecules-11-00011">
 <label>166.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>McDougall</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>King</surname>
    <given-names>P.J.</given-names>
   </name>
   <name>
    <surname>Wu</surname>
    <given-names>B.W.</given-names>
   </name>
   <name>
    <surname>Hostomsky</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Reinecke</surname>
    <given-names>M.G.</given-names>
   </name>
   <name>
    <surname>Robinson</surname>
    <given-names>W.E.</given-names>
   </name>
  </person-group>
  <article-title>Dicaffeoylquinic and Dicaffeoyltartaric acids are selective inhibitors of human immunodeficiency virus type 1 integrase</article-title>
  <source>Antimicrob. Agents Chemother.</source>
  <year>1998</year>
  <volume>42</volume>
  <fpage>140</fpage>
  <lpage>146</lpage>
  <pub-id pub-id-type="doi">10.1128/AAC.42.1.140</pub-id>
  <?supplied-pmid 9449274?>
  <pub-id pub-id-type="pmid">9449274</pub-id>
 </element-citation>
</ref>
